Metabolic Abnormalities, Lifestyle and Diet Pattern in Heart Failure

NCT03951311 · tracked via the Priya Life Science China tracker

Sponsor

Ruijin Hospital

Phase

Observational

Started

2016-06-01

Last updated

2021-10-08

Condition(s) studied

Heart FailureMetabolic Disease

Study summary

Metabolic abnormalities (e.g., hypertension, diabetes mellitus, dyslipidemia, and obesity) and unhealthy lifestyle behaviors (e.g., smoking and drinking habits, sedentary behavior, sleep disorder and physical inactivity) and unhealthy diet (e.g., high sugar and high fat) are major risk factors for cardiovascular diseases mobility and mortality. The investigators sought to estimate the impact of metabolic abnormalities, lifestyle behavior and diet pattern on prognosis of heart failure. This study planned to consecutively enroll 1,500 participants with heart failure with reduced ejection fraction and heart failure with mid-range ejection fraction fulfilling the inclusion criteria. Each heart failure survivors will be followed up for 5 years. Information on metabolic diseases, lifestyle and diet pattern were obtained through standardized questionnaire. The major adverse cardiac events will be identified by reviewing pertinent medical records and discharge lists from the hospitals, or official death certificates collected at local death registration centers, or directly contacting participants' family. The Cox proportional hazard model will be used to assess the association between metabolic risk factors and lifestyle and diet habits and health outcomes in heart failure patients.

Eligibility

Sex

ALL

Min age

14 Years

Max age

90 Years

Healthy volunteers

Inclusion Criteria: 1. aged 14 years or older; 2. typical symptoms of heart failure according to the Framingham criteria; 3. left ventricular ejection fraction (LVEF) \<50%, demonstrated by echocardiography or cardiac magnetic resonance, which include either patients with mid-range EF (HFmEF) or with reduced EF (HFrEF) with relevant structural and functional cardiac changes and/or elevated N-terminal pro-brain B-type natriuretic peptide (pro-BNP) (e.g., ≥400 pg/mL). Exclusion Criteria: 1. age \<14 years or ≥90 years; 2. pregnancy; 3. cancer with a life expectancy of less than one year; 4. participation in other trials; 5. endocarditis, pericardial diseases, or congenital heart diseases; 6. heart failure secondary to non-cardiac diseases (e.g., pulmonary heart disease, infection, infiltration, metabolic derangements, severe anemia, sepsis, and arteriovenous fistula); 7. lack of informed consent; 8. refusal of the drug treatment or intervention recommended by the guidelines.

Primary outcome measure(s)

a composite of cardiovascular mortality or hospitalization due to subjectively and objectively worsening HF — 5 years
An independent committee of experts including three physicians reviews all the death certificates and medical records for adjudicating the death cases and all suspected CVD cases biennially from the index episode, via telephone contacting patients' family members or reviewing medical records and the Hospital Discharge Register data.

Trial sites (1)

Facility	City	Region	Status
Ruijin Hospital, Shanghai Jiaotong University School of Medicine	Shanghai	Shanghai Municipality	Recruiting

More Ruijin Hospital trials in China

PET Imaging Targeting Granzyme B Predicts Immunotherapy Efficacy in Diffuse Large B-cell Lymphoma Recruiting

A Multimodal Prospective Cohort Study of Parkinsonism Recruiting

PRogression of Atheroma Evaluated by CT Angiography and IntraCoronary Imaging tEchniques Recruiting

The Efficacy of Allo-HSCT in ND HR-CBF-AML Recruiting

Efficacy and Safety of Radical Prostatectomy (RP) With or Without Salvage Radiotherapy Versus RP With Extended Pelvic Lymph Node Dissection for Localized Intermediate- and High-risk Prostate Cancer With a Briganti Nomogram≥7% Recruiting

Other trials for the same condition

Non-invasive Filling Pressure(NIFP) Device Based on Low Frequency Heart Sound in Assessment of Congestion in Heart Failure Patients Recruiting

Effect of Finerenone on Myocardial Fibrosis and Cardiac Function in HFmrEF/HFpEF Patients Starting soon

HARMONY Trial : To Evaluate a Therapeutic and Monitoring Device(NOVAtria System) for Heart Failure Management Recruiting

Community Exercise Treating Effect on Cardiopulmonary Disease Patients Recruiting

A Clinical Study of HRS-7156 in Healthy Participants Recruiting

Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT03951311 on ClinicalTrials.gov ↗ ← All trials in China